Tapering is best reserved for those in complete remission with stable disease for at least 6 months, although many individual patient characteristics must be taken into account, experts say.
One patient desperate to get Evusheld is Imogen Dempsey (pictured), 43, from Colchester. The risk analyst suffers a condition that means she has not responded to vaccines.